No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score

Luke P Dawson,Muhammad Rashid,Diem T Dinh,Angela Brennan,Jason E Bloom,Sinjini Biswas,Jeffrey Lefkovits,James A Shaw,William Chan,David J Clark,Ernesto Oqueli,Chin Hiew,Melanie Freeman,Andrew J Taylor,Christopher M Reid,Andrew E Ajani,David M Kaye,Mamas A Mamas,Dion Stub,Luke P. Dawson,Diem T. Dinh,Jason E. Bloom,James A. Shaw,David J. Clark,Andrew J. Taylor,Christopher M. Reid,Andrew E. Ajani,David M. Kaye,Mamas A. Mamas,on behalf of the MIG and BCIS Investigators
DOI: https://doi.org/10.1161/circinterventions.123.013738
2024-03-16
Circulation Cardiovascular Interventions
Abstract:Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Suboptimal coronary reperfusion (no reflow) is common in acute coronary syndrome percutaneous coronary intervention (PCI) and is associated with poor outcomes. We aimed to develop and externally validate a clinical risk score for angiographic no reflow for use following angiography and before PCI.METHODS:We developed and externally validated a logistic regression model for prediction of no reflow among adult patients undergoing PCI for acute coronary syndrome using data from the Melbourne Interventional Group PCI registry (2005–2020; development cohort) and the British Cardiovascular Interventional Society PCI registry (2006–2020; external validation cohort).RESULTS:A total of 30 561 patients (mean age, 64.1 years; 24% women) were included in the Melbourne Interventional Group development cohort and 440 256 patients (mean age, 64.9 years; 27% women) in the British Cardiovascular Interventional Society external validation cohort. The primary outcome (no reflow) occurred in 4.1% (1249 patients) and 9.4% (41 222 patients) of the development and validation cohorts, respectively. From 33 candidate predictor variables, 6 final variables were selected by an adaptive least absolute shrinkage and selection operator regression model for inclusion (cardiogenic shock, ST-segment–elevation myocardial infarction with symptom onset >195 minutes pre-PCI, estimated stent length ≥20 mm, vessel diameter <2.5 mm, pre-PCI Thrombolysis in Myocardial Infarction flow <3, and lesion location). Model discrimination was very good (development C statistic, 0.808; validation C statistic, 0.741) with excellent calibration. Patients with a score of ≥8 points had a 22% and 27% risk of no reflow in the development and validation cohorts, respectively.CONCLUSIONS:The no-reflow prediction in acute coronary syndrome risk score is a simple count-based scoring system based on 6 parameters available before PCI to predict the risk of no reflow. This score could be useful in guiding preventative treatment and future trials.
cardiac & cardiovascular systems
What problem does this paper attempt to address?